The DOI matches its Crossref record; 220 of the 227 references it cites were found in a registry or an index.
Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
Open accessAbstract
Elevated protein synthesis is an important feature of many cancer cells and often arises as a consequence of increased signaling flux channeled to eukaryotic initiation factor 4F (eIF4F), the key regulator of the mRNA–ribosome recruitment phase of translation initiation. In many cellular and preclinical models of cancer, eIF4F deregulation results in changes in translational efficiency of specific mRNA classes. Importantly, many of these mRNAs code for proteins that potently regulate critical cellular processes, such as cell growth and proliferation, enhanced cell survival and cell migration that ultimately impinge on several hallmarks of cancer, including increased angiogenesis, deregulated growth control, enhanced cellular survival, epithelial-to-mesenchymal transition, invasion, and metastasis. By being positioned as the molecular nexus downstream of key oncogenic signaling pathways (e.g., Ras, PI3K/AKT/TOR, and MYC), eIF4F serves as a direct link between important steps in cancer development and translation initiation. Identification of mRNAs particularly responsive to elevated eIF4F activity that typifies tumorigenesis underscores the critical role of eIF4F in cancer and raises the exciting possibility of developing new-in-class small molecules targeting translation initiation as antineoplastic agents. Cancer Res; 75(2); 250–63. ©2014 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Many direct eIF4A/eIF4F mRNA targets have been identified and often encode proteins that drive proliferation, metastasis, and survival (11, 14, 15).”
From Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer (2023) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–220 of 220
Rotili, D., Tarantino, D., Artico, M., Nawrozkij, M. B., González-Ortega, E., Clotet, B., Samuele, A., Esté, J. A., Maga, G., & Mai, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101626c · Cited by 53
Saradhi, U. V. R. V., Gupta, S. V., Chiu, M., Wang, J., Ling, Y., Liu, Z., Newman, D. J., Covey, J. M., Kinghorn, A. D., Marcucci, G., et al. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9273-x · Cited by 50
Borman, A. M., Michel, Y. M., Malnou, C. E., & Kean, K. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205065200 · Cited by 50
Ribavirin is not a functional mimic of the 7-methyl guanosine mRNA cap
Yan, Y., Svitkin, Y. V., Lee, J. M., Bisaillon, M., & Pelletier, J. (2005) · RNA · doi:10.1261/rna.2930805 · Cited by 50
Self-citationEukaryotic Initiation Factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer
Zhou, S., Wang, G., Liu, C., & Zhou, M. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-231 · Cited by 49
Cap accessibility correlates with the initiation efficiency of alfalfa mosaic virus RNAs
Godefroy-Colburn, T., Ravelonandro, M., & PINCK, L. (2008) · European Journal of Biochemistry · doi:10.1111/j.0014-2956.1985.00549.x · Cited by 46
Westman, B. J., Beeren, L., Grudzien‐Nogalska, E., Stȩpiński, J., Worch, R., Zuberek, J., Jemielity, J., Stolarski, R., Darżynkiewicz, E., Rhoads, R. E., et al. (2005) · RNA · doi:10.1261/rna.2132505 · Cited by 44
Lawson, T. G., Hadzopoulou‐Cladaras, M., Ray, B. K., Lee, K. A. W., Abramson, R. D., Merrick, W. C., & Thach, R. E. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68637-5 · Cited by 43
Shantz, L. M., Coleman, C. S., & Pegg, A. E. (1996) · PubMed · Cited by 37
Horikami, S. M., de Ferra, F., & Moyer, S. A. (1984) · Virology · doi:10.1016/0042-6822(84)90142-9 · Cited by 37
Homeostasis in mRNA Initiation
Luo, Y., & Goss, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104970200 · Cited by 36
Poornachandran, M., Takrouri, K., Chen, T., Sahoo, R., Papadopoulos, E., Chen, L., Wagner, G., Aktas, B. H., Halperin, J. A., & Chorev, M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401733v · Cited by 31
Asselbergs, F. A. M., Peters, W. H. M., VENROOIJ, W. J. V., & BLOEMENDAL, H. (1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb12473.x · Cited by 30
Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells
Chen, E. Z., Jacobson, B. A., Patel, M. R., Okon, A. M., Shui, L., Xiong, K., Vaidya, A. J., Bitterman, P. B., Wagner, C. R., & Kratzke, R. A. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0076-7 · Cited by 23
Hayashi, S., Nishimura, K., Shimogori, T., Kashiwagi, K., & Igarashi, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3637 · Cited by 23
Jonák, J., Rychlík, I., Smrt, J., & Holý, A. (1979) · FEBS Letters · doi:10.1016/0014-5793(79)80210-0 · Cited by 23
Brown, C. J., Lim, J., Leonard, T. A., Lim, H., Chia, C. S. B., Verma, C. S., & Lane, D. P. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.10.045 · Cited by 23
y Cajal, S. R., Mattos‐Arruda, L. D., Sonenberg, N., Cortés, J., & Peg, V. (2014) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1203-9 · Cited by 22
Self-citationTumor progression and metastasis: role of translational deregulation.
Nasr, Z., & Pelletier, J. (2012) · PubMed · Cited by 15
Self-citationYang, Y. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i8.1707 · Cited by 12
Cited by
Sorted by citations
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Chio, I. I. C., Jafarnejad, S. M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., Öhlund, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.056 · Cited by 378
“Of the four phases of protein synthesis (initiation, elongation, termination, and recycling), initiation is considered to be the rate-limiting step in mRNA translation and is often exploited by cancer cells to support tumorigenesis (Pelletier et al., 2015).”
InfluentialSelf-citationGenome editing of upstream open reading frames enables translational control in plants
Zhang, H., Si, X., Ji, X., Fan, R., Liu, J., Chen, K., Wang, D., & Gao, C. (2018) · Nature Biotechnology · doi:10.1038/nbt.4202 · Cited by 373
Translation from unconventional 5′ start sites drives tumour initiation
Sendoel, A., Dunn, J. G., Rodriguez, E. H., Naik, S., Gomez, N. C., Hurwitz, B. S., Levorse, J. M., Dill, B. D., Schramek, D., Molina, H., et al. (2017) · Nature · doi:10.1038/nature21036 · Cited by 339
Kern, L., Mittenbühler, M., Vesting, A., Ostermann, A., Wunderlich, C., & Wunderlich, F. (2018) · Cancers · doi:10.3390/cancers11010024 · Cited by 331
Metadata
- Authors
- Pelletier, J., Graff, J., Ruggero, D., & Sonenberg, N.
- Affiliations
- Institut du cancer Rosalind & Morris Goodman (CA)
- Eli Lilly (United States) (US)
- University of California, San Francisco (US)
- Corresponding author
- Pelletier, Jerry
- Venue
- Cancer Research
- Published
- 2015-01-14
- Volume
- 75
- Issue
- 2
- Pages
- 250-263
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC4299928
- OpenAlex
- W2005176113
- Cited by
- 367
- References
- 227
- Citations by year
- 2026: 18 · 2025: 18 · 2024: 30 · 2023: 36 · 2022: 30 · 2021: 39 · 2020: 32 · 2019: 35 · 2018: 40 · 2017: 33 · 2016: 37 · 2015: 19
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- U.S. Public Health Service (MOP-106530, MOP-115126)
- National Cancer Institute (R01CA140456, R01CA184624, R01CA154916)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Keywords
- eIF4F, translation initiation, cancer, translational regulation, oncogenic signaling, Ras, c-Myc, metastasis, epithelial-mesenchymal transition, angiogenesis, cell proliferation
- MeSH terms
- Animals, Antineoplastic Agents, Humans, Neoplasms, Eukaryotic Initiation Factor-4F, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
